Lupin board to consider unaudited financial results

15 Oct 2013 Evaluate

Lupin has informed that a meeting of the Board of Directors of the company will be held on October 30, 2013 to consider and take on record unaudited financial results for the quarter ended September 30, 2013 (Q2).

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2121.65 -25.95 (-1.21%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×